Illumina, Inc. issued a press release on November 9, 2026, announcing an early access program for a new ultrasensitive duplex sequencing workflow designed to detect circulating tumor DNA in plasma samples for molecular residual disease research.
Nkarta, Inc. filed an 8-K on November 9, 2026, disclosing initial clinical data from its Phase 1/2 Ntrust-2 basket study and integrated safety data from its Ntrust-1 and Ntrust-2 trials evaluating NKX019 in myositis and systemic sclerosis, presented at ACR Convergence 2026.
Citigroup Global Markets Holdings Inc. filed a free writing prospectus on November 9, 2026, disclosing preliminary terms for 6-Year Buffer Securities linked to the S&P 500 Index, with a pricing date of November 23, 2026, and maturity on November 29, 2032.
Surgery Partners, Inc. filed a current report on Form 8-K on November 9, 2026, disclosing that it entered into Amendment No. 1 to its Agreement and Plan of Merger on November 8, 2026, increasing the merger consideration and revising related terms of its previously …
TMC The Metals Company Inc. filed a Form 8-K on November 9, 2026, disclosing that its subsidiary TMC USA received a letter from NOAA on November 3, 2026, stating that NOAA expects to notify TMC USA by mid-December 2026 of its final determination on …
Community Trust Bancorp Inc /KY/ Executive Vice President Andy D. Waters filed a Form 4 on November 9, 2026, disclosing a disposition of 320 shares of common stock on November 6, 2026.
Cullen/Frost Bankers, Inc. filed a notification with the SEC on November 9, 2026, seeking the voluntary withdrawal of its Common Stock and Series B preferred depositary shares from listing and registration on the New York Stock Exchange.
Fox Corporation filed an Amendment No. 1 to its Form 8-K on November 9, 2026, supplementing its original November 6, 2026 current report to provide historical financial statements of Roku, Inc. and required pro forma financial information following the completion of the Roku acquisition.
TriGemX Bio, Inc. filed a Form 425 on November 9, 2026, disclosing the appointment of Daniel Lynch as Chairman of the TriGemX Bio Board of Directors in connection with the company's proposed business combination with TCGX Acquisition Corp. (NASDAQ:TCGX).
David E. Lazar filed an initial statement of beneficial ownership with the SEC on November 9, 2026, disclosing his acquisition of preferred shares in Highway Holdings Ltd (NASDAQ:HIHO) following a securities purchase agreement dated November 4, 2026.